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efepime-tazobactam: A promising therapeutic option
.N. Panchatcharam1,∗, V. Ramasubramanian1, R.
opalakrishnan2, A. Ghafur1, M. Thirunarayan3
Apollo Hospitals, Chennai, India
Apollo Hospital, Chennai, India
Apollo Hospital, 600006, T.N, IndiaBackground: In the era of carbapenem resistance, the use of
ffective beta lactam - beta lactamase inhibitor (BL - BLI) combi-
ation drugs could serve as a carbapenem sparing strategy in the
ppropriate clinical situation. We therefore attempted to study thefectious Diseases 16S (2012) e317–e473
in vitro susceptibilities of cefepime-tazobactam, a new BL - BLI
combination drug.
Methods: Our hospital is a 600 bed tertiary care centre located
in South India. A total of 450 clinical isolates were studied
during the study period from August 2010 till January 2012.
Identiﬁcation and susceptibility testing to ceftazidime, cefepime,
piperacillin-tazobactam, cefoperazone-sulbactam and imipenem
was done by both Vitek 2 compact (BioMerieux, France) and
Kirby-Bauer’s disk diffusion method using CLSI guidelines 2011.
Cefepime-tazobactam (30/10g Hi Media, Mumbai) was tested by
Kirby-Bauer’s disk diffusion method. The cefepime zone size as per
CLSI 2011 was used to interpret cefepime-tazobactam sensitivities
as no criteria for cefepime-tazobactam is available.
Results: The 450 samples studied included 230 urinary isolates,
70 respiratory isolates, 55 pus samples, 50 bacteremic isolates and
45 isolates from tissue. The antibiotic susceptibility observed is as
shown in the table.
Name of the bacteria Ceftazidime Cefepime Piperacillin/
tazobactam
Cefoperazone/
sulbactam
Cefepime/
tazobactam
Imipenem
E coli (n =204) 40.8% 40% 67.2% 81.6% 91.4% 97.4%
Klebsiella (n =100) 35.7% 35.7% 51.7% 71.4% 76.7% 80.3%
Pseudomonas (n=54) 67.8% 82.4% 85.7% 67.8% 85.7% 64.2%
Acinetobacter (n =32) 28.5% 35% 50% 57% 50% 42.9%
Others* (n =60) 64.5% 64.5% 77.4% 80.6% 83.8% 87%
* Proteus, Enterobacter, Morganella, Providencia, Citrobacter, Serratia
Conclusion: Cefepime-tazobactam is a promising option in the
management of infections due to enterobacteriaceae and pseu-
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ity of the patients to provide samples and chronicity/severity of the
disease cannot be made.
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valuation of inﬂuenza RT-PCR assay competency
. Klungthong, N. Charoensri, V. Pobkeeree ∗, K. Hussem, S.
ernandez, K.M. Bauer
Armed Forces Research Institute of Medical Sciences, Bangkok,
hailand
Background: InﬂuenzaA andB are themost prevalent inﬂuenza
iruses around the globe. The real time RT-PCR is used to rapidly
dentify the viruses in nasal and/or throat swabs. The test includ-
ng the viral genome extraction and the target gene ampliﬁcation
teps is needed to be performed very carefully to provide good sen-
itivity and speciﬁcity aswell as to avoid contamination. Evaluation
f the assay performance is indispensable. AFRIMS initiated a pilot
rogram and assembled sample panel composed of characterized
nﬂuenzaA subtypeH1andH3and inﬂuenzaB sampleswhichwere
istributed to four sites. This panel aimed to evaluate the perfor-
ance of the lab and its personnel at all sites and evaluate the
uality of the panel’s consistency over the past three years.
Methods: AFRIMS prepared three trials of quality control pan-
ls to detect inﬂuenza A and B during three consecutive years
2009-2011). Each control panel consisted of 10 samples contain-
ng different concentrations of heat-inactivated inﬂuenza viruses.
ne panel comprised of coded numbers of inﬂuenza A, H1, high
nd low concentrations; inﬂuenza A, H3, high and low concentra-
ions; inﬂuenza B, high and low concentrations; and four negative
amples. The panels were sent to four sites and tested by using
otor-Gene Thermal Cycler platform.
Results:The results of cycle thresholdvalues (Ct)wereanalyzed.
he trials’ standard deviation (SD) and coefﬁcient of variation (%
V) of Ct value from each positive sample were calculated. Ct data
rom 2009 to 2011 had SD and % CV between 1.03 -2.03 and 1.06%
4.16% respectively. Total datasets were concordant 90.50% of the
ime (86/95). The rate of false positive and negative results varied
rom1 to 6.3% over the past three years depending on the virus
ubtype.
Conclusion: The coefﬁcient of variation values obtained from
ll trialswere consistentwith other quality assessment studies that
eported % CV generally less than 8%. Further on-site and refresher
ourse training should be held periodically to decrease false posi-
ive andnegative results. Both the panel provider and lab personnel
ust strictly follow SOPs in order tominimize variations and errors
f testing.
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Success rate of direct sputum smear microscopy (DSSM) for AFB
among psychiatric patients in a Philippine government Psychi-
atric healthcare facility
B. Seludo ∗, C.A. Azucena
national center for mental health, Quezon, Please select region, state
or province, Philippines
Background: The transmission rate of pulmonary tuberculosis
among patients in mental institutions can be as high as sixteen-
times more than that of the general population. Although the
Tuberculosis Program (NTP) of the Department of Health (DOH)
recommends direct sputum smearmicroscopy in diagnosing active
tuberculosis, chest radiographs remain the primary method for
detecting TB in psychiatric patients conﬁned in mental hospitals
due to uncooperative/aggressive behavior. The rate of case detec-
tion through sputum microscopy in these patients has yet to be
determined.
This study aims to determine the percentage of patients, admit-
ted in the NCMH-TB Pavilions for the period of June 1, 2010 - May
31, 2011, able to provide adequate sputum samples for the micro-
biologic diagnosis of tuberculosis.
Methods: Two hundred and sixteen (216) patients diagnosed
with pulmonary tuberculosis through chest radiographs were
included in the study. Three sputum specimens were submit-
ted by all subjects under the instruction and direct observation
of TB DOTS-trained nurses, following the Department of Health
protocols, regarding sputum collection. Sputum samples were
classiﬁed as either adequate for culture or inadequate (<10 epithe-
lial cells/hpf). Samples were subsequently examined using Ziehl
Neelsen staining procedure to identify the presence of acid-fast
bacilli regardless of their adquacy for culture.
Results: Of 216 patients, 174 (81%) were able to provide ade-
quate sputumsamples for thediagnosis of tuberculosis. Fromthese,
37 (17%) tested positive for acid fast bacilli in their sputum at least
once during 3 collections. Forty-two patients (19%) were not able
to provide adequate specimens due to behavioral difﬁculties.
Conclusion: Direct sputum smear microscopy is a method that
would aid in the diagnosis of active pulmonary tuberculosis among
patients with psychiatric disorders.
Such technique avoids the over diagnosis of the disease, as seen
when chest radiographs are solely utilized. However, given the
cross-sectional design of the study, associations between the abil-
